Although certain European countries already regulate aluminium in parenteral nutrition solutions (PNS), there are currently no European standards limiting the maximum amount of aluminium in these solutions, which are often prepared extemporaneously. To address this situation, the European Pharmacopoeia (Ph. Eur.) is seeking qualified professionals with expertise in PNS and parenteral preparations, particularly those with experience of quality and toxicological assessment of aluminium content, to join the newly created Aluminium in parenteral solutions Working Party (ALU WP). This WP will be responsible for drafting a new general chapter on Aluminium in parenteral nutrition solutions to help limit the risk of exposure to toxic levels of aluminium. The text is also expected to include guidance for those preparing and administering these solutions.
If you have experience in this field and would like to share your expertise and work closely with colleagues from around the world, the staff of the European Directorate for the Quality of Medicines & HealthCare (EDQM), scientists and European regulators, then please check whether you match the Profile for experts in the ALU WP Terms of reference (Terms of reference and profile for members of groups of experts and working parties), and then submit your application via your national pharmacopoeia authority or the EDQM HelpDesk. For more details, please see the “Join the Network” web page.
See also: